Skip to content
WeighLab

Ivy Rx vs Next Vial

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Ivy Rx

Provider comparison

Patients comparing a low advertised compounded starting price who will check the exact molecule, plan total and renewal terms.

Semaglutide / month
$77/moFrom (standard shared GLP-1 injection headline, compounded; confirm selected plan)
Tirzepatide / month
Not separately disclosed (shared compounded GLP-1 headline from $77/mo)
Index 76/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Ivy Rx pricing Read review

Next Vial

Provider comparison

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Semaglutide / month
$199/moMonth-to-month, all doses, compounded
Tirzepatide / month
$249/moMonth-to-month, all doses, compounded
Index 76/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Next Vial pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 76/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Ivy Rx
Not published; confirm eligibility
Next Vial
49 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Ivy Rx

Next Vial

Semaglutide / month
Ivy Rx: $77/moFrom (standard shared GLP-1 injection headline, compounded; confirm selected plan)
Next Vial: $199/moMonth-to-month, all doses, compounded
Tirzepatide / month
Ivy Rx: Not separately disclosed (shared compounded GLP-1 headline from $77/mo)
Next Vial: $249/moMonth-to-month, all doses, compounded
Semaglutide / year (modeled)
Ivy Rx: $924
Next Vial: $2,388
Tirzepatide / year (modeled)
Ivy Rx: —
Next Vial: $2,988
State availability
Ivy Rx: Not published; confirm eligibility
Next Vial: 49 states
Oral / sublingual option listed
Ivy Rx: Not listed
Next Vial: Not listed
Brand-name access listed
Ivy Rx: Yes
Next Vial: Not confirmed
Provider facts checked
Ivy Rx: October 2026
Next Vial: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Ivy Rx

Patients comparing a low advertised compounded starting price who will check the exact molecule, plan total and renewal terms.

Reasons to consider it

  • Publishes a $77 standard injection headline and separate $69 microdose option
  • Says the injection price stays the same at every dose
  • Includes same-day physician review and free delivery

What to weigh up

  • The shared starting headline does not establish a separate public tirzepatide price
  • No full state list or individual dispensing pharmacy is published
  • Terms describe one- or three-month initial plans followed by monthly automatic renewal

Compounded drugs are not FDA-approved. Understand the medication options.

Check Ivy Rx pricing Read the full Ivy Rx review

Next Vial

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Reasons to consider it

  • Names Manifest Pharmacy as a dispensing partner
  • Displays a LegitScript verification link
  • Publishes a 49-state coverage list, excluding Alaska

What to weigh up

  • The lowest advertised monthly equivalents require paying for a longer supply up front
  • The page headline differs from the actual plan selector, so use the selected plan total
  • No individual medical director is named

Compounded drugs are not FDA-approved. Understand the medication options.

Check Next Vial pricing Read the full Next Vial review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Ivy RxNext Vial
Normalized Cost/Month
Ivy Rx:
97/100
Next Vial:
68/100
Price Transparency
Ivy Rx:
94/100
Next Vial:
97/100
Nationwide Access
Ivy Rx:
24/100
Next Vial:
78/100
Formulation Options
Ivy Rx:
66/100
Next Vial:
66/100
Clinical Oversight
Ivy Rx:
82/100
Next Vial:
82/100
Contract Flexibility
Ivy Rx:
85/100
Next Vial:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to Ivy RxAlternatives to Next Vial
More provider matchups
CoreAge Rx vs Ivy RxCoreAge Rx vs Next Vial
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.